Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.

Enalapril, the new converting enzyme inhibitor, was administered to eight patients with heart failure (NYHA Functional Class II to IV) during standardised and intensive haemodynamic, hormone, and electrolyte monitoring. The first dose (5 mg) of enalapril induced a fall in plasma angiotensin II and n...

Descrición completa

Detalles Bibliográficos

Publicado en:	Br Heart J
Principais autores:	Fitzpatrick, D, Nicholls, M G, Ikram, H, Espiner, E A
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMJ Publishing Group 1983
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481390/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6309203/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.50.2.163
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!